Balanced news tone
News Sentiment
AKUMS sentiment intelligence
AKUMS DRUGS AND PHARMA L news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
76/100 classification confidence.
directly relevant articles
high-authority source matches
+12.0% over one week, +13.2% over four weeks, trend active, and near fair-value range.
Akums AGM approves dividend, MD pay amid opposition
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Akums AGM approves dividend, MD pay amid opposition
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 10 Jul 2026 16:13
- Source
- scanx.trade
Akums FY26 revenue rises 5.9% to ₹43,590.17 Mn
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 19 Jun 2026 07:00
- Source
- scanx.trade
Akums files BRSR for FY 2025-26 reporting improved energy intensity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- scanx.trade
Akums Drugs and Pharmaceuticals to attend investor meets on June 15
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 09:20
- Source
- scanx.trade
Market Trading Guide: Akums Drugs among 4 stock recommendations for Thursday
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- The Economic Times
Akums Drugs and Pharmaceuticals to host InsightX 2026 virtual meet
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- scanx.trade
Akums subsidiaries face ₹156 cr tax demand
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 23 May 2026 07:00
- Source
- scanx.trade
Akums Drugs Q4 profit declines, but EBITDA jumps 62%; declares special dividend
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 14 May 2026 07:00
- Source
- CNBC TV18
Akums Drugs P Standalone March 2026 Net Sales at Rs 338.37 crore, up 2.93% Y-o-Y
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 May 2026 07:00
- Source
- Moneycontrol.com
Akums Drugs Q4 Net Profit Falls 42.4% to ₹86.4 Crore Amid Margin Pressures
- Tone
- Negative 36/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Sahi
Akums Drugs Pharma Scores 63 ESG Rating from NSE Analytics
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 08 May 2026 07:00
- Source
- Whalesbook
Akums Drugs and Pharmaceuticals Receives ESG Rating of 63 for FY2024-25
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 08 May 2026 07:00
- Source
- scanx.trade
Akums Drugs and Pharmaceuticals Limited Just Beat Revenue Estimates By 9.0%
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 18 Feb 2026 08:00
- Source
- simplywall.st
Akums Drugs rises 6% as ICICI Sec hikes target price; projects 39% upside
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 17 Feb 2026 08:00
- Source
- Business Standard
Akums Drugs & Pharma - 10 Nifty500 stocks with upside potential of up to 55%. Do you own any?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Feb 2026 08:00
- Source
- The Economic Times
Akums Drugs and Pharmaceuticals Limited's (NSE:AKUMS) Stock Is Going Strong: Have Financials A Role To Play?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 24 Dec 2025 08:00
- Source
- simplywall.st
Quadria Capital sells entire stake in Akums for Rs 311 crore
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 24 Dec 2025 08:00
- Source
- Medical Dialogues
Quadria Capital exits Akums Drugs Pharma; sells 4.6 pc stake for Rs 311 cr
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 23 Dec 2025 08:00
- Source
- ETPharma.com
Akums Drugs shares jump 8% after ICICI Prudential MF buys stake
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 23 Dec 2025 08:00
- Source
- Business Standard
Ruby QC Investment Holdings exits Akums Drugs, sells entire 4.6% stake to ICICI Prudential Mutual Fund
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 22 Dec 2025 08:00
- Source
- Moneycontrol.com
Akums Drugs & Pharma appoints Yuvraj Datta as President - Operational Strategy & Excellence
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Nov 2025 08:00
- Source
- Medical Dialogues
Akums Drugs Share Price Falls 3% as Q2 Profit Drops 36% YoY; Near 52-Wk Low
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Nov 2025 08:00
- Source
- HDFC Sky
Akums Drugs & Pharma Unveils Strong FY25 Performance and Global Expansion Plans
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 27 May 2025 07:00
- Source
- eHealth Magazine
Income Tax raid on Akums Drugs & Pharma; company breaks silence
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jan 2025 08:00
- Source
- Healthcare Radius
Akums Drugs And Pharmaceuticals Ltd | Stock Share Price Live
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Oct 2024 09:45
- Source
- MarketSmith India
Akums Drugs & Pharma IPO: Public Issue Subscribed 22x On Day 3, GMP Soars; Don't Miss Out On Dates
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 01 Aug 2024 07:00
- Source
- Goodreturns